CD28 and neoplasm: This may be attributed to the inadequate activation of T cells in the tumor microenvironment, such as insufficient CD28 costimulation signal, or the presence of immunosuppressive T cells in the immunosuppressive microenvironment, characterized by elevated levels of LAG3, PD-1, and TIM3.